Department of Microbiology, College of Medicine, University of Iowa, Iowa City, Iowa 52240.
Infect Immun. 1971 Jan;3(1):16-23. doi: 10.1128/iai.3.1.16-23.1971.
A subcellular extract prepared from nonencapsulated Diplococcus pneumoniae type 3 protected mice against a subsequent challenge with virulent D. pneumoniae types 1, 2, 3, and 7. Potency ratios ranged from 25 (type 3) to >1,175 (type 1). The immunity induced in mice by this preparation was best obtained by intraperitoneal inoculation followed by intravenous challenge. Mice immunized in this manner were protected up to 12 weeks and could withstand a challenge of several hundred LD(50). The protection was destroyed by treatment of the preparation with ribonuclease and was decreased by treatment with protease. The preparation consisted of 60.5% ribonucleic acid, 29.1% protein, 6.3% deoxyribonucleic acid, and 4.0% hexose. Ultracentrifugation studies indicated that this extract had five constituents which are compatible with ribosomal material.
从非包裹型 3 型肺炎双球菌制备的亚细胞提取物可保护小鼠免受随后的强毒 1、2、3 和 7 型肺炎双球菌的攻击。效力比范围从 25(3 型)到>1,175(1 型)。该制剂在小鼠中诱导的免疫力通过腹腔接种后静脉内攻击获得最佳效果。以这种方式免疫的小鼠可保护长达 12 周,并且可以承受数百 LD(50)的挑战。该制剂用核糖核酸酶处理后可破坏保护作用,并经蛋白酶处理后可降低保护作用。该制剂由 60.5%的核糖核酸、29.1%的蛋白质、6.3%的脱氧核糖核酸和 4.0%的己糖组成。超速离心研究表明,该提取物有五种成分与核糖体物质相容。